Identification and characterization of epsilon-sarcoglycans in the central nervous system
about
Sam68 regulates a set of alternatively spliced exons during neurogenesisCytoplasmic prion protein induces forebrain neurotoxicityEarlier onset of motor deficits in mice with double mutations in Dyt1 and Sgce.Exclusive paternal expression and novel alternatively spliced variants of epsilon-sarcoglycan mRNA in mouse brain.Gene expression profiles during early differentiation of mouse embryonic stem cells.Abnormal nuclear envelope in the cerebellar Purkinje cells and impaired motor learning in DYT11 myoclonus-dystonia mouse modelsAlteration of striatal dopaminergic neurotransmission in a mouse model of DYT11 myoclonus-dystonia.SGCE isoform characterization and expression in human brain: implications for myoclonus-dystonia pathogenesis?Abnormal nuclear envelopes in the striatum and motor deficits in DYT11 myoclonus-dystonia mouse modelsMetabolic changes in DYT11 myoclonus-dystonia.Epsilon sarcoglycan mutations and phenotype in French patients with myoclonic syndromesThe neurobiology of the dystrophin-associated glycoprotein complex.Faithful SGCE imprinting in iPSC-derived cortical neurons: an endogenous cellular model of myoclonus-dystonia.Milestones in dystonia.Role of major and brain-specific Sgce isoforms in the pathogenesis of myoclonus-dystonia syndrome.The interaction between cytoplasmic prion protein and the hydrophobic lipid core of membrane correlates with neurotoxicity.Myoclonus dystonia and muscular dystrophy: ɛ-sarcoglycan is part of the dystrophin-associated protein complex in brain.No muscle involvement in myoclonus-dystonia caused by epsilon-sarcoglycan gene mutations.
P2860
Q24655267-B8AE8BF9-8DD4-4464-B896-297F04E37A23Q30488090-854520A8-04C1-40E2-8AC6-C4DB82B0ED4AQ30497374-36ABE5D2-92A9-4F8A-A9F6-468E81B1FC76Q30999843-DAA681A1-97C8-4983-B1AB-827A4610865AQ33398806-DB6D8F95-8D1D-4ADD-9BF9-BE9F876EF663Q34063055-E2068393-2875-434B-A0CD-B6F7282A4252Q34206423-38FE04FC-89C6-4290-91BE-E933E7B9616FQ34694722-D3F552D1-584B-4EF8-A9C5-EDD08EDE1ABDQ35688598-1D0CC65C-30EB-433E-9120-B09829C78B74Q36659593-32235A0F-C116-46EF-8BD4-3C6EEE307474Q36930029-24EC9458-EF11-4305-835B-B18CE109F534Q37378530-73BCA8F0-0855-4782-AD76-0997C74A5BA5Q37623123-582DC50C-F353-4888-9033-EDC8F1A718E9Q37882600-59042EEF-D1BD-4C07-84A2-FC3EC3653A2EQ39150577-E22E50A7-9BED-4F3F-A71F-509BA9F6EAC1Q40305093-D67B1908-7303-4C51-9BB8-7BE7D0A7524FQ41878236-BADDF773-9DD2-4E40-93E2-27B5E30993FFQ46691080-ED7B33DF-0A78-4B97-A11F-13C14056DA4B
P2860
Identification and characterization of epsilon-sarcoglycans in the central nervous system
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Identification and characterization of epsilon-sarcoglycans in the central nervous system
@ast
Identification and characterization of epsilon-sarcoglycans in the central nervous system
@en
Identification and characterization of epsilon-sarcoglycans in the central nervous system
@nl
type
label
Identification and characterization of epsilon-sarcoglycans in the central nervous system
@ast
Identification and characterization of epsilon-sarcoglycans in the central nervous system
@en
Identification and characterization of epsilon-sarcoglycans in the central nervous system
@nl
prefLabel
Identification and characterization of epsilon-sarcoglycans in the central nervous system
@ast
Identification and characterization of epsilon-sarcoglycans in the central nervous system
@en
Identification and characterization of epsilon-sarcoglycans in the central nervous system
@nl
P2093
P3181
P1476
Identification and characterization of epsilon-sarcoglycans in the central nervous system
@en
P2093
Akiyo Nishiyama
Michihiro Imamura
Shin'ichi Takeda
Takeshi Endo
P3181
P356
10.1016/J.MOLBRAINRES.2004.01.012
P407
P577
2004-06-18T00:00:00Z